Edison Oncology Holding Corp. (EOHC)
Edison Oncology Holding will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$8.00 - $10.00
Shares Offered
2,827,777
Deal Size
$25.45M
Edison Oncology Holding Revenue
Edison Oncology Holding had revenue of $446.09K in the twelve months ending September 30, 2025. In the year 2024, Edison Oncology Holding had annual revenue of $377.19K, down -21.73%.
Revenue (ttm)
$446.09K
Revenue Growth
-21.73%
P/S Ratio
167.09
Revenue / Employee
n/a
Employees
n/a
Market Cap
74.54M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 377.19K | -104.74K | -21.73% |
| Dec 31, 2023 | 481.93K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionEOHC News
- 7 days ago - Edison Oncology IPO Registration Document (S-1) - SEC
- 7 days ago - Phase 2 oncology biotech Edison Oncology Holding files and sets terms for a $25 million IPO - Renaissance Capital